Peptide and oligonucleotide CDMO market seen reaching $11.42 billion by 2035
SNS Insider said the market was valued at $3.34 billion in 2025 and is projected to expand at a 13.10% CAGR as outsourcing, peptide therapeutics and precision medicine demand grow.